chrisvoncsefalvay/vaers-outcomes huggingface dataset:
after 2nd vaccine he could barely raise his left arm above his head; arm pain left; usual chills; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 26-May-2021. The most recent information was received on 27-Jul-2021 and was forwarded to Moderna on 27-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MOVEMENT DISORDER (after 2nd vaccine he could barely raise his left arm above his head), PAIN IN EXTREMITY (arm pain left) and CHILLS (usual chills) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 7006320004 and 7006320001) for COVID-19 vaccination.     The patient's past medical history included Cancer. Previously administered products included for an unreported indication: INFLUENZA. Concurrent medical conditions included Coronary disease.   On 01-Sep-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Oct-2020, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Oct-2020, the patient experienced MOVEMENT DISORDER (after 2nd vaccine he could barely raise his left arm above his head), PAIN IN EXTREMITY (arm pain left) and CHILLS (usual chills). On 14-Oct-2020, CHILLS (usual chills) had resolved. On 17-Oct-2020, MOVEMENT DISORDER (after 2nd vaccine he could barely raise his left arm above his head) and PAIN IN EXTREMITY (arm pain left) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PAIN IN EXTREMITY (arm pain left) and CHILLS (usual chills) to be possibly related. No further causality assessment was provided for MOVEMENT DISORDER (after 2nd vaccine he could barely raise his left arm above his head).    No treatment information or concomitant medications were provided by reporter. Action taken with the drug in response to the events was not provided by the Reporter.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow-up received included no new information. On 27-Jul-2021: Significant follow up received - Patient demographics, medical history, vaccination facility details updated, new event pain in arm added, stop date for event chills were updated.
Fever; Pain in hip; Back pain; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), ARTHRALGIA (Pain in hip) and BACK PAIN (Back pain) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medial history reported).    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PYREXIA (Fever), ARTHRALGIA (Pain in hip) and BACK PAIN (Back pain). At the time of the report, PYREXIA (Fever), ARTHRALGIA (Pain in hip) and BACK PAIN (Back pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included aspirin.   Reporter did not allow further contact
Developed significant arthritis pain in left forefinger 3 days after booster.  Subsided after 10 days. Developed shingles in left arm and hand 10 days after booster.  Shingles ran the full course.  Was prescribed Valacyclovir, gabapentin, and oxycodone.  Still healing from shingles.
Pt felt dizzy, had vasovagal syncope, hit head on metal stanchion and then the ground.
This case was reported by a nurse via call center representative and described the occurrence of hematocrit decreased in a 86-year-old male patient who received SHINGRIX for prophylaxis. On 27th June 2018, the patient received the 1st dose of SHINGRIX. On 25th July 2018, 28 days after receiving SHINGRIX, the patient experienced hematocrit decreased and hemoglobin decreased. On an unknown date, the outcome of the hematocrit decreased and hemoglobin decreased were unchanged. It was unknown if the reporter considered the hematocrit decreased and hemoglobin decreased to be related to SHINGRIX. Additional details were provided as follows: The patient's wife reported the case for the patient. The patient had routine CBC labs (complete blood count) taken on 25th July 2018. The patient's hematocrit was at 38 and hemoglobin count was 14. A repeat laboratory was done on 5th October 2018 and the hematocrit went to 36. Iron levels and reticulocyte counts were normal. The reporter agreed to have a letter from Safety sent to her for physician information.
Patient got vaccinated at 10:22 a.m. At 10:35 a.m., patient reported severe headache, chest tightness, difficulty breathing, feeling lightheaded. Patient noted to be diaphoretic, less responsive, and having left eye deviation. Patient assessed/examined by Dr. and Medics on site. Vital signs taken: at 10: 38 a.m., BP 177/126, HR 118; at 10:39 a.m., BP 172/120, HR 110,  O2saturation 96% on room Air; at 10:41 a.m., BP 173/123, BG: 333, sinus rhythm on cardiac monitor. At 10:47 a.m., BP 158/78 (with manual cuff). Fire Metro Paramedics called; Patient transported to Hospital at 11 a.m.
My whole body started to ache, like I was having a flare up of shingles, joints ached, loss of energy and fatigue. It lasted for about a week.
Approx 10 days after pt had the vaccination, I (her husband) developed shingles-see S-1 op Merck "Prescribing Information"
Pancytopenia/rash; diagnosed with hemophagocytic lymphohistiocytosis.  Discharge Summary received on 11/29/2004 states pt experienced anorexia, fever, fatigue, and heptosplenomegaly.
Information regarding Prevnar (pneumococcal 7-valent conjugate vaccine (diphtheria crml97 protein) injection) was received from a physician regarding a 2 month old male patient who developed redness, swelling and a red streak going up the side of his thigh. At 2 months of age, the pt received a dose on 10/26/2004. Event Details: On 10/27/2004, A 2 month old male pt developed swelling, redness, and a red streak going up the side of his thigh. (erythema) after receiving an injection of Prevnar. The child was examined by a physician: treatment was not administered. No additional information was available at the time of this report. Manufacturers Comment: This is one of 2 patients from this facility who experienced this event following receipt of Prevnar lot No. A83578E. See related HQWYE334610NOV04.
Right arm red,swollen, warm to touch from shoulder to elbow 1 day after recieving DTAP. Temperature 100.1. Seen on office with 9X11cm area of redness right deltoid. Right arm circumference 23.5cm compared to 21 cm on left arm. Painful to touch. Ice packs, tylenol or motrin.
Itchy  red rash around injection site appeared approximately 7 days after injection. About 2 inches around
On 03/25/2000 the patient developed an itchy rash on the right side of her neck and stomach. The rash was noted as slightly raised and fluid filled. On 04/06/2000 the patient recovered. No further information is available.
This spontaneous report as received from an other health professional refers to a patient of unknown age. On 20-JUL-2017, the patient was vaccinated with GARDASIL 9 lot # M042853 for prophylaxis. No adverse effects were reported. Data logger was involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1708USA004692: US-009507513-1708USA004693: US-009507513-1708USA004694: US-009507513-1708USA004695: US-009507513-1708USA004690: US-009507513-1708USA002122.
This is a spontaneous report from a contactable consumer (patient). A 61-year-old male patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# FC3180), at the age of 61, via an unspecified route of administration, left arm, on Aug 27, 2021, at 14:00, single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. The patient has no known allergies. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# FA6780), at the age of 61, via an unspecified route of administration, left arm, on Jul 31, 2021, at 19:30, single dose, for COVID-19 immunisation. On an unknown date in 2021, patient experienced 3 weeks of diarrhea. The event did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures taken as a result of event included self-treatment with Imodium (loperamide hydrochloride). Since the vaccination, patient has not been tested for COVID-19. The outcome of the event 3 weeks of diarrhea was unknown at the time of the report.
Pt developed hives immediately after MMR, DTaP, IPV. shots administered in pt's thighs. No shortness of breath or wheezing noted. Pt doing ok otherwise. No other symptoms. Dr ordered 15mg Oraprid that was given.
Within a couple of hours my arm became extremely weak.  My arm and hand have a strange sensation  are extremely weak and I cannot grip anything or lift my arm above my shoulder.  My armpit is swollen and sore.  I vomited that evening and have no appetite.  Every joint in my body feels like it is burning.  I am completely exhausted, dizzy, and light headed.   I have not sought medical attention because I cannot afford the cost.  I am hoping it will resolve but this is the third day.
reported onset of mild headache and bilateral visual field defects (black spots) that got worse with sitting and standing vs. lying down, started at 4:30pm. Phone call at 5:30pm with Dr. She had gotten her covid vaccine earlier that day at 9am. She was feeling better by the time I had called her, and we tested her vision over the phone and she denied any black spots at the time, so I advised Tylenol 1000mg and call me at any point if things get worse. Plan to follow up with eye doctor on Saturday 1/16/2021.
During vaccine injection felt pain up left cheek and down back of arm.  A week later had numbness/tingling in ring and pinky finger.  Has had numbness, tingling for about 1-1/2 months now.  Arm feels weak at times and has wrist twitching sometimes at night.
headache; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the parent.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headache".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Red hot spot at the site of injection; warm to touch.; A spontaneous report was received from a nurse concerning herself, a 64-year-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced a red hot spot in her left arm was warm to the touch.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 30-Dec-2020, the patient received their first of two planned doses of mRNA-1273 (Lot/Batch number unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   The patient reported that on day 2 after receiving the first injection, 01-Jan-2021, she noticed at the site of the injection a red hot spot in her left arm that was warm to the touch. She put an ice pack on the arm because she noticed it was hot.   Treatment for the event included paracetamol and cold therapy.    Action taken with mRNA-1273 in response to the events was unknown.   The outcome of the events, red hot spot in her left arm was warm to the touch, was considered unknown.; Reporter's Comments: This case concerns a 64-year-old female who had nonserious events of unexpected vaccination site warmth and expected vaccination site erythema.  Event onset occurred 3 days after the first dose of mRNA-1273. Treated with Tylenol. Based on current available information and temporal association between use of the product and the start date of the vaccination site warmth and vaccination site erythema, a causal relationship cannot be excluded.
head hurts; could not raise it; sore to touch; back was hurting; neck and head hurts; still a dark shade of red; was really sore in the lymph nodes on the left side; has a knot at the injection site; legs were weak; it is red; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (head hurts), INJECTION SITE ERYTHEMA (it is red), PAIN IN EXTREMITY (arm was sore), MOVEMENT DISORDER (could not raise it) and VACCINATION SITE MASS (has a knot at the injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Osteoporosis and Spinal disorder. Concomitant products included LISINOPRIL, DESLORATADINE (CLARINEX [DESLORATADINE]), PROBIOTICS NOS, VITAMINS NOS and OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was sore). On 20-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (it is red), VACCINATION SITE MASS (has a knot at the injection site), ASTHENIA (legs were weak) and LYMPH NODE PAIN (was really sore in the lymph nodes on the left side). On 12-Apr-2021, the patient experienced MACULE (still a dark shade of red). On an unknown date, the patient experienced HEADACHE (head hurts), MOVEMENT DISORDER (could not raise it), PAIN (sore to touch), BACK PAIN (back was hurting) and NECK PAIN (neck and head hurts). The patient was treated with AMOXICILLIN at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ALCOHOL for Cooling therapy, at an unspecified dose and frequency. At the time of the report, HEADACHE (head hurts), INJECTION SITE ERYTHEMA (it is red), PAIN IN EXTREMITY (arm was sore), MOVEMENT DISORDER (could not raise it), VACCINATION SITE MASS (has a knot at the injection site), ASTHENIA (legs were weak), PAIN (sore to touch), BACK PAIN (back was hurting), NECK PAIN (neck and head hurts), LYMPH NODE PAIN (was really sore in the lymph nodes on the left side) and MACULE (still a dark shade of red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Additional treatment includes: cold compresses  Patient reports that second dose will be 13-April-2021   Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: Added events(follow-up note) and event assessment, changed action items for the same.Added dates from the follow-up document for initial events.Added medication in i-narrative supplement.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 11-JAN-2017, the patient was vaccinated with an improperly stored dose of VARIVAX, lot number M033906, expiration date 20-JUL-2018 (dose, route and anatomical location were not reported) for prophylaxis (incorrect product storage). The vaccine was exposed to temperature of -5 Fahrenheit (F) (-20 Celsius(C)) and to the lowest recorded temperature of -14 F (-25C) during 4 hours and 5 minutes. The storage type was reported as "data logger". There was no previous temperature excursion. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.; Sender's Comments: US-009507513-1701USA012890: US-009507513-1701USA013083: US-009507513-1701USA013084: US-009507513-1701USA013085: US-009507513-1701USA013086: US-009507513-1701USA013087: US-009507513-1701USA013088: US-009507513-1701USA013089: US-009507513-1701USA013090: US-009507513-1701USA013092: US-009507513-1701USA013093: US-009507513-1701USA013094: US-009507513-1701USA013095: US-009507513-1701USA013096: US-009507513-1701USA013097: US-009507513-1701USA013098: US-009507513-1701USA013099: US-009507513-1701USA013100: US-009507513-1701USA013101: US-009507513-1701USA013102: US-009507513-1701USA013103: US-009507513-1701USA013104: US-009507513-1701USA013105: US-009507513-1701USA013106: US-009507513-1701USA013107: US-009507513-1701USA013108: US-009507513-1701USA013109: US-009507513-1701USA013110: US-009507513-1701USA013082:
Patient stated: "All I know is I came from over there when I took that injection , I opened the freezer, I opened the cooler, that's all  I remember ma'am." Temp: 97.6 Pulse 100, Resp:20, B/P: 157/87 Oxygen saturation 100%.
Decreased lactation. The patient pumps, and has noticed 50% decrease in production Narrative:
Blood Pressure was Sky High; Ringing in ears; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for covid-19 Immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for covid-19 Immunization. The following information was reported: HYPERTENSION (non-serious), outcome "unknown", described as "Blood Pressure was Sky High"; TINNITUS (non-serious), outcome "unknown", described as "Ringing in ears". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: The patient took the booster. He didn't have any problems with the first two but with the Booster, his blood pressure was sky high and he had ringing in his ears and the vaccine didn't work too good with the 3rd one. He states with the first 2 he felt okay, but the booster messed him up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN ACUTE PULMONARY EMBOLISM 12/11/2022 &  2/14/2023 --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Moderna COVID-19 Vaccine EUA Fever, joint pain, fatigue, headache, chills
Information has been received from a medical assistant concerning a 56 year old patient who on 10/28/02 was vaccinated with a dose of pneumococcal vaccine 23 polyvalent (lot # 641532/1353L). On approximately 10/28/02 the patient developed a swollen arm and flu-like symptoms such as nausea and vomiting. This was not the first dose of pneumococal vaccine 23 polyvalent that the patient had received. The patient sought unspecified medical attention. A product quality complaint was not involved. The medical assistant also provided information regarding another patient's experience after vaccination with a dose of pneumococcal vaccine 23 polyvalent. Additional information has been requested.
MMRV given IM instead of SC. MA notified Lead RN. Doctor was notified. Pharmacy was consulted. We have attempted to contact the patient's mother by phone several times but have been unable to reach her. I mailed a letter to her today asking her to contact our office.
Ongoing tingling sensation across face (especially on forehead, below eyes around the noise, and cheeks).  Sensitivity when blinking eyes.   Took Claritin and Zrytek for two weeks attempting to counteract the reaction.  Went to my Primary Physician  on April 19.  He prescribed Methylprednisolone 4MG Dospak.  Started to feel some relief, took second vaccine and symptoms acceleted again.  Finished the Methylprednisolone and still struggling with this reaction. After feeling sensations moving from my face to my arms and legs, went to emergency room.
pale body, headaches (sinus), tired (slept all day Saturday) fever, on Wednesday 4/18 feels much better.
Her neck was getting inflamed; Has her neck inflamed on the left side of her neck, on the side where the shot was given; She has a ball on her collarbone like a tiny ball and when she touches, it hurts; She has a ball on her collarbone like a tiny ball; This is a spontaneous report from a contactable consumer (patient's Daughter). A 49-year-old female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, Solution for injection, Lot Number: ER8731), via an unspecified route of administration on an unspecified date into Arm Left as a single dose for COVID-19 immunisation. Medical history included thyroid disorder from an unknown date and unknown if ongoing Verbatim: Thyroid. Concomitant medication(s) included hydroxyzine, levothyroxine. On an unspecified date, the patient had a ball on her collarbone like a tiny ball and when she touches, it hurts and she also has her neck inflamed on the left side of her neck, on the side where the shot was given, the shot was given on her arm, but her arm is okay. Her mother received the first dose of Pfizer-BioNTech COVID-19 Vaccine and they reported that her neck was getting inflamed and described it as a little ball on top of her collarbone. So, I have provided the information to the caller with regards to what to do about the side effects and to reach out to their doctor or healthcare professional. Reporter stated that She got the ball on Saturday and the information yesterday. She didn't get any information; she was just given a paper on the site and it said for those who wanted to know the side effect of having neck getting inflamed to go ahead and call. We don't know who the doctor was we just know that it was in a complex. No name was given like we don't know the information who gave the vaccine, what doctors were there, we know that it was in a complex and there were a bunch of tables where they were administrating the vaccine. It was 'hererson/pureous fort complex' (not clarified). She did not have the schedule for the second dose, they are going to let us know. She was just mainly worried about her neck and what to do about that. Reason of delay: Daily spike of incoming calls due to COVID19 vaccine. The patient did not receive any treatment for the events. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Seizure lasting 30-40 minutes.  11/10/09:  ER Report received for date of service 11/05/09.  DX:  Partial complex seizure, new diagnosis, recent H1N1 vaccine.    Assessment:  Brought into ER 20 min. after being found on floor at home having difficulty breathing.  She had cough that was weird in its sound, but would not speak and did not respond to her parents.  There was slight drooling during the episode.  Upon exam that child was blinking abnormally, not responding to directions or looking at her parents or the doctor.  Upon command to stand she did have some awkward limping type movements involving the left foot that has a plantar wart on it.  She began to act normally when the rectal exam was attempted.  Pt. sent to x-ray and on return her neurological status was normal.  She was alert, holding on to mom, pointing toward the TV.  She still walked with a limp, but a much more normal walk.  Plan:  To follow up with outpatient MRI and EEG.  11/20/09 Medical records received for dates 11/6/09 and 11/16/09.  OV 11/16 Rash over lower back/buttocks area. Seizure 11/14 x5min per parent. Assessment: (+)rash, mechanical pattern. Seizures referred to neurologist. OV 11/6/09 f/u ER visit.
Two days after immunization she awoke with symptoms of dizziness, mild nausea and low grade headache.